13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 66 holding rows worth $969,614,000.
- Accession
- 0001172661-22-000859
- Filer
- CIK 1792126
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 66 entries on the cover page, a total value of $969,614,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $969,614,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 2,906,352 | $62,458,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,325,000 | $60,394,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,772,501 | $59,359,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 870,000 | $52,957,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,000,000 | $47,280,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 1,664,251 | $42,122,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 300,000 | $39,300,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 3,234,392 | $38,457,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 3,112,785 | $36,949,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,550,000 | $36,642,000 | thousands by filing date | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 1,824,280 | $36,230,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 1,700,000 | $35,853,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,743,875 | $35,043,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,450,000 | $24,244,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 1,600,000 | $22,752,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 750,000 | $21,953,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,300,000 | $21,736,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,630,744 | $21,249,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 443,265 | $16,343,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,120,000 | $15,512,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 1,930,000 | $14,572,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 850,000 | $12,988,000 | thousands by filing date | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 200,000 | $12,698,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 865,000 | $12,283,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 685,000 | $12,118,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 1,350,000 | $11,273,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 614,095 | $9,739,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 400,000 | $9,012,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 250,000 | $8,550,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 475,000 | $8,412,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 50,000 | $7,335,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 625,000 | $7,219,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 473,394 | $6,660,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 300,000 | $6,630,000 | thousands by filing date | |
| LANDOS BIOPHARMA INC | 515069102 | CMN | 1,375,000 | $6,600,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 35,000 | $5,935,000 | thousands by filing date | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 1,339,793 | $5,908,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 350,000 | $5,688,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 94,000 | $5,500,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 250,000 | $5,185,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 454,545 | $5,118,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 406,308 | $5,050,000 | thousands by filing date | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 329,013 | $5,031,000 | thousands by filing date | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 1,100,000 | $4,906,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 288,458 | $4,450,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 250,000 | $4,053,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 2,000,000 | $3,900,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 299,853 | $3,760,000 | thousands by filing date | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 185,196 | $3,653,000 | thousands by filing date | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 245,161 | $3,158,000 | thousands by filing date | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 286,652 | $3,144,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 100,000 | $3,104,000 | thousands by filing date | |
| NUVALENT INC COM | 670703107 | Stock | 134,650 | $2,563,000 | thousands by filing date | |
| LIANBIO ADR | 53000N108 | COM | 412,837 | $2,543,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 800,000 | $2,512,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 200,493 | $2,333,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 252,320 | $1,879,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 130,000 | $1,544,000 | thousands by filing date | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 50,000 | $1,336,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 150,000 | $1,287,000 | thousands by filing date | |
| OMEGA THERAPEUTICS INC | 68217N105 | COMMON STOCK | 88,235 | $999,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 122,000 | $820,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 37,069 | $624,000 | thousands by filing date | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 70,000 | $508,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $126,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 46,984 | $75,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-22-000859 | this filing | 2022-02-14 | acceptance time not in the bulk data set |